- ... 11297944 ] Prahm KP, Feldt-Rasmussen U, Vissing J. Human growth hormone stabilizes walking and improves strength in a patient ...
- ... Y, Yoshimoto M (2004) Clinical evaluation of recombinant human growth hormone in Noonan syndrome. Endocr J 51:61-8 [ ...
- ... C, Wang C, Liu Y. Effectiveness of recombinant human growth hormone therapy for children with Phelan-McDermid syndrome: an ...
- ... but generally do not recover lost height unless human growth hormone is administered. Prevention of secondary complications : Those who ...
- ... Bertelloni S, Massart F. Height outcome of recombinant human growth hormone treatment in achondroplasia children: a meta-analysis. Horm ...
- ... al 2014 ]. Treatment of short stature. Injections of human growth hormone alone or in combination with gonadotropin-releasing hormone ( ...
- ... related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated ...
- ... are short for their age. Mecasermin is a human insulin-like growth factor (hIGF) analog. It works by replacing a hormone that promotes normal growth of bones and tissues.
- ... although there have not been sufficient studies in humans with pathogenic ARID1B variants who are receiving growth hormone clinically to determine if this therapy is of ...
- ... HER2-directed therapy Trastuzumab [ 1 , 5 ] Pertuzumab HER2 = human epidermal growth factor receptor 2; LHRH = luteinizing hormone-releasing hormone. Tamoxifen Evidence (tamoxifen): A retrospective analysis ...
626 results